Australia's Memphasys gains 40% on orders from Qatari customer

Memphasys

02/02/2026 04:20

** Shares of Memphasys MEM.AX rise 40% to A$0.007, their highest level since Jan 15
** Co says that Hamad Medical Corporation, Qatar's largest IVF institution, commences commercial ordering of Felix cartridges for clinical use
** Felix system is co's patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction
** Shares dropped 28.6% in January

 (Reporting by Nichiket Sunil in Bengaluru)

 ((Nichiket.Sunil@thomsonreuters.com))